China Medical System Holdings Limited
CHSYF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $4,001,980 | $3,857,921 | $3,611,069 | $3,403,158 |
| % Growth | 3.7% | 6.8% | 6.1% | – |
| Cost of Goods Sold | $1,110,068 | $1,132,227 | $914,569 | $933,097 |
| Gross Profit | $2,891,912 | $2,725,694 | $2,696,500 | $2,470,061 |
| % Margin | 72.3% | 70.7% | 74.7% | 72.6% |
| R&D Expenses | $202,489 | $224,407 | $105,575 | $119,394 |
| G&A Expenses | $430,817 | $418,588 | $361,505 | $338,644 |
| SG&A Expenses | $1,855,282 | $1,679,777 | $1,761,964 | $1,510,365 |
| Sales & Mktg Exp. | $1,424,465 | $1,261,189 | $1,400,459 | $1,171,721 |
| Other Operating Expenses | $0 | -$82,043 | $0 | $0 |
| Operating Expenses | $2,057,771 | $1,822,141 | $1,867,539 | $1,629,759 |
| Operating Income | $834,141 | $903,553 | $828,961 | $840,302 |
| % Margin | 20.8% | 23.4% | 23% | 24.7% |
| Other Income/Exp. Net | $309,904 | -$29,582 | $307,375 | -$249,123 |
| Pre-Tax Income | $1,144,045 | $873,971 | $1,136,336 | $591,179 |
| Tax Expense | $212,552 | $164,293 | $232,934 | $122,700 |
| Net Income | $941,178 | $709,362 | $910,426 | $479,884 |
| % Margin | 23.5% | 18.4% | 25.2% | 14.1% |
| EPS | 0.39 | 0.29 | 0.37 | 0.2 |
| % Growth | 34.5% | -21.6% | 85% | – |
| EPS Diluted | 0.39 | 0.29 | 0.37 | 0.2 |
| Weighted Avg Shares Out | 2,418,529 | 2,427,382 | 2,438,362 | 2,451,991 |
| Weighted Avg Shares Out Dil | 2,418,526 | 2,427,382 | 2,438,356 | 2,451,989 |
| Supplemental Information | – | – | – | – |
| Interest Income | $36,564 | $126,344 | $0 | $87,176 |
| Interest Expense | $0 | $38,610 | $0 | $0 |
| Depreciation & Amortization | $105,049 | $145,175 | $114,063 | $105,756 |
| EBITDA | $939,190 | $1,365,131 | $943,024 | $946,058 |
| % Margin | 23.5% | 35.4% | 26.1% | 27.8% |